TY - JOUR
T1 - Angiogenesis gene expression profiling in xenograft models to study cellular interactions
AU - Thijssen, Victor L J L
AU - Brandwijk, Ricardo J M G E
AU - Dings, Ruud P M
AU - Griffioen, Arjan W
N1 - Copyright 2004 Elsevier Inc.
PY - 2004/10/1
Y1 - 2004/10/1
N2 - The present study describes a method to simultaneously obtain the angiogenic expression profile in tumor cells and vascular cells of a single tumor. Human- and mouse-specific primers were used for quantitative real-time RT-PCR to determine the expression of vascular endothelial growth factors A, B, C, and D, vascular endothelial growth factor receptors 1, 2, and 3, neuropilin 1 and 2, angiopoietin 1, 2, 3/4, tyrosine kinase receptors 1 and 2, basic fibroblast growth factor (bFGF) in xenograft tumors obtained by injection of human ovarian carcinoma cells in nude mice. In addition, the effect of treatment with anginex and taxol on the expression profile was analyzed. Most factors were expressed higher in vascular cells as compared to tumor cells. In response to treatment, tumor cells significantly upregulated bFGF expression and downregulated VEGF receptor expression. This was accompanied by downregulation of VEGF-B and -D, and upregulation of angiopoietin-3 as well as angiopoetin receptors in nontumor cells. In conclusion, real-time qRT-PCR combined with xenograft tumor models presents a sensitive method to monitor angiogenesis and to analyze interactions between tumor cells and nontumor cells in vivo. The approach can be applied to different research fields in which xenograft models are used.
AB - The present study describes a method to simultaneously obtain the angiogenic expression profile in tumor cells and vascular cells of a single tumor. Human- and mouse-specific primers were used for quantitative real-time RT-PCR to determine the expression of vascular endothelial growth factors A, B, C, and D, vascular endothelial growth factor receptors 1, 2, and 3, neuropilin 1 and 2, angiopoietin 1, 2, 3/4, tyrosine kinase receptors 1 and 2, basic fibroblast growth factor (bFGF) in xenograft tumors obtained by injection of human ovarian carcinoma cells in nude mice. In addition, the effect of treatment with anginex and taxol on the expression profile was analyzed. Most factors were expressed higher in vascular cells as compared to tumor cells. In response to treatment, tumor cells significantly upregulated bFGF expression and downregulated VEGF receptor expression. This was accompanied by downregulation of VEGF-B and -D, and upregulation of angiopoietin-3 as well as angiopoetin receptors in nontumor cells. In conclusion, real-time qRT-PCR combined with xenograft tumor models presents a sensitive method to monitor angiogenesis and to analyze interactions between tumor cells and nontumor cells in vivo. The approach can be applied to different research fields in which xenograft models are used.
KW - Angiogenesis Inhibitors/pharmacology
KW - Angiogenic Proteins/genetics
KW - Animals
KW - Antineoplastic Agents/pharmacology
KW - Base Sequence
KW - Disease Models, Animal
KW - Female
KW - Gene Expression Profiling
KW - Gene Expression Regulation, Neoplastic
KW - Humans
KW - Melanoma/blood supply
KW - Mice
KW - Molecular Sequence Data
KW - Neovascularization, Pathologic/genetics
KW - Ovarian Neoplasms/blood supply
KW - Paclitaxel/pharmacology
KW - RNA, Messenger/genetics
KW - Reverse Transcriptase Polymerase Chain Reaction
KW - Sequence Homology, Nucleic Acid
KW - Skin Neoplasms/blood supply
KW - Transplantation, Heterologous
U2 - 10.1016/j.yexcr.2004.06.014
DO - 10.1016/j.yexcr.2004.06.014
M3 - Article
C2 - 15350528
SN - 0014-4827
VL - 299
SP - 286
EP - 293
JO - Experimental Cell Research
JF - Experimental Cell Research
IS - 2
ER -